RWP
IDXX icon

Revolve Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Revolve Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Buy
963
+68
+8% +$38.1K 0.05% 188
2026
Q1 		$503K Buy
895
+25
+3% +$16K 0.07% 129
2025
Q4 		$589K Sell
870
-2
-0.2% -$1.36K 0.07% 122
2025
Q3 		$557K Buy
872
+8
+0.9% +$4.86K 0.07% 122
2025
Q2 		$463K Buy
864
+3
+0.3% +$1.44K 0.06% 132
2025
Q1 		$362K Buy
861
+7
+0.8% +$3.04K 0.05% 148
2024
Q4 		$353K Sell
854
-73
-8% -$32K 0.05% 146
2024
Q3 		$468K Buy
+927
New +$450K 0.07% 120

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Revolve Wealth Partners's IDXX Position: Q2 2026 in Review

Revolve Wealth Partners increased its Idexx Laboratories (IDXX) stake by 7.6% in Q2 2026, buying an estimated $38.1K and bringing the position to 963 shares worth $507K. The position accounts for 0.05% of the portfolio, ranked #188.

Revolve Wealth Partners first reported a position in IDXX in Q3 2024 and has held it in 8 quarters since. The position peaked at $589K in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Revolve Wealth Partners held 963 shares of Idexx Laboratories worth $507K as of Q2 2026.
  • Revolve Wealth Partners bought 68 Idexx Laboratories shares in Q2 2026, an estimated $38.1K.
  • Idexx Laboratories made up 0.05% of Revolve Wealth Partners's portfolio in Q2 2026, its #188 holding.
  • Revolve Wealth Partners first reported a position in Idexx Laboratories in Q3 2024 and has held it in 8 quarters since.
  • Revolve Wealth Partners's Idexx Laboratories position peaked at $589K in Q4 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.